Showing results (271-280 of 304) with videos related to
Sort By:
Pageof 31
Leukemia|May 24, 2016
Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosisC N Harrison, A M Vannucchi, J-J Kiladjian, et al.Blood|March 9, 2000
Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO)A Bacigalupo, B Bruno, P Saracco, et al.The Hematology Journal : the Official Journal of the European Haematology Association|June 26, 2001
Risk-oriented postremission strategies in adult acute lymphoblastic leukemia: prospective confirmation of anthracycline activity in standard-risk class and role of hematopoietic stem cell transplants in high-risk groupsR Bassan, E Pogliani, P Casula, et al.Leukemia|February 9, 2016
Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or bothS Koschmieder, T I Mughal, H C Hasselbalch, et al.Leukemia|September 20, 2011
Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteriaG Finazzi, A Carobbio, J Thiele, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2006
Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALTL Arcaini, S Burcheri, A Rossi, et al.The American Journal of Medicine|May 1, 1996
Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian RegistryG Finazzi, V Brancaccio, M Moia, et al.Frontiers in Cardiovascular Medicine|December 15, 2023
Clinical variables associated with late-onset thrombotic and cardiovascular events, after SARS-CoV-2 infection, in a cohort of patients from the first epidemic wave: an 18-month analysis on the "Surviving-COVID" cohort from Bergamo, ItalyS V Benatti, S Venturelli, G Crotti, et al.Haematologica|January 1, 1997
Mobilization and collection of PBSC in healthy donors: a retrospective analysis of the Italian Bone Marrow Transplantation Group (GITMO)I Majolino, A M Cavallaro, A Bacigalupo, et al.Leukemia Research|August 10, 2010
What are RBC-transfusion-dependence and -independence?R P Gale, G Barosi, T Barbui, et al.Pageof 31